MAPT and Cognitive impairment: While aSyn might be a parameter for measuring the pathological hallmark of the disease, NfL, iron, and ferritin levels have the potential to predict the progression of the disease, while β-amyloid and potentially p-Tau are promising to forecast cognitive impairment.